Ira DuBey MBA PhD
Chief Commercial Officer, Pharmaceutical Development Services
Dr. DuBey has over 30 years of senior executive experience managing and building science-based businesses. Ira is serving as a Chief Commercial Officer (CCO) and Emeritus President at Pharmaceutical Development Services Division, and Chairman of the Advisory Board at Smithers. In this capacity, he is responsible for the management of the business and continued growth strategy, and in ensuring that there is alignment between scientific expertise, and business expansion into appropriate sectors.
Prior to Smithers, Ira held the position of Vice President and General Manager of Biotechnology Services for Tandem Labs, Inc. a LabCorp Company. He conceived and built the business at Tandem Labs that supported the development of large molecule drugs (biologics) and therapeutic vaccines. Prior to Tandem Labs, he held the position of Director of Immunochemistry Services for Covance Laboratories, Inc. In this capacity he was responsible for providing laboratory services that supported NIH work as well as the development of large molecule drugs, such as protein drugs and MAB drugs. The facility was both a GLP laboratory and CLIA certified and supported both pre-clinical and clinical development. Dr. DuBey holds an M.S. degree in Toxicology from the University of Maryland Graduate School, an M.B.A. from the Johns Hopkins University and a Ph.D. from the Graduate Center of CUNY.
Prior to Smithers, Ira held the position of Vice President and General Manager of Biotechnology Services for Tandem Labs, Inc. a LabCorp Company. He conceived and built the business at Tandem Labs that supported the development of large molecule drugs (biologics) and therapeutic vaccines. Prior to Tandem Labs, he held the position of Director of Immunochemistry Services for Covance Laboratories, Inc. In this capacity he was responsible for providing laboratory services that supported NIH work as well as the development of large molecule drugs, such as protein drugs and MAB drugs. The facility was both a GLP laboratory and CLIA certified and supported both pre-clinical and clinical development. Dr. DuBey holds an M.S. degree in Toxicology from the University of Maryland Graduate School, an M.B.A. from the Johns Hopkins University and a Ph.D. from the Graduate Center of CUNY.